Moderna (MRNA) Rockets 17% on Strong Preliminary FY25 Results

We recently published 10 Stocks Leaving Wall Street in the Dust; 4 Hit Fresh Records. Moderna Inc. (NASDAQ:MRNA) was one of the top performers on Tuesday. Moderna rebounded by 17.02 percent on Tuesday to finish at $39.60 apiece as investors took heart from the preliminary results of its earnings performance in full-year 2025. At the 44th Annual JP Morgan Healthcare Conference on Monday, Moderna Inc. (NASDAQ:MRNA) said that it expects to report revenues of $1.9 billion for full-year 2025, or $100 million ...